After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Denali Therapeutics Inc is $3.32B. A total of 1.0 million shares were traded on the day, compared to an average of 913.44K shares.
In the most recent transaction, Ho Carole sold 12,255 shares of DNLI for 20.22 per share on Jan 06 ’25. After the transaction, the Chief Medical Officer now owns 178,580 company shares. In a previous transaction on Jan 07 ’25, Ho Carole sold 2,907 shares at 20.81 per share. DNLI shares that Chief Medical Officer owns now total 175,673.
Among the insiders who sold shares, Schuth Alexander O. disposed of 12,255 shares on Jan 06 ’25 at a per-share price of $20.22. This resulted in the COFO and Secretary holding 247,215 shares of DNLI after the transaction. In another insider transaction, Schuth Alexander O. sold 2,907 shares at $20.81 per share on Jan 07 ’25. Company shares held by the COFO and Secretary now total 244,308.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DNLI has a high of $33.33 and a low of $14.56.
As of this writing, DNLI has an earnings estimate of -$0.84 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.69 per share and a lower estimate of -$1.0.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DNLI’s latest balance sheet shows that the firm has $865.41M in Cash & Short Term Investments as of fiscal 2021. There were $64.01M in debt and $378.25M in liabilities at the time. Its Book Value Per Share was $9.17, while its Total Shareholder’s Equity was $962.29M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DNLI is Buy with a score of 4.89.
